Glaxosmithkline | GSK - Заемный капитал

Биржевая цена
55.21
Изменение за день
-3.91 -6.61%
Ежемесячно
-9.76%
Ежегодный
40.48%
Q1 прогноз
57.89




Заемный капитал Изменить Дата
AbbVie USD 62.97B 12M 2025-09
Amgen USD 50B 2.43B 2025-12
AstraZeneca USD 26.14B 19.58B 2025-12
Aurora Cannabis CAD 34.99M 1.31M 2025-09
Bausch Health Companies USD 20.62B 152M 2025-12
Bristol-Myers Squibb USD 42.85B 1.62B 2025-12
Canopy Growth CAD 226.33M 62.67M 2025-09
Drreddys Laboratories INR 129.19M 1.84M 2025-12
Eli Lilly USD 40.87B 5.6M 2025-12
GlaxoSmithKline GBP 14.71B 186M 2025-12
Glaxosmithkline GBP 20.02B 4.72B 2025-09
J&J USD 39.44B 30M 2025-12
Merck USD 39.97B 6B 2025-09
Novartis USD 24.24B 174M 2025-09
Pacira USD 372.19M 4.53M 2025-12
Perrigo USD 3.6B 4.5M 2025-12
Pfizer USD 57.41B 93M 2025-09
Phibro Animal Health USD 603.6M 5.92M 2025-12
Prestige Brands USD 1.05B 39.73M 2025-12
Roche Holding CHF 27.43B 966M 2025-12
Sanofi EUR 15.72B 2.45B 2025-12
Supernus Pharmaceuticals USD 400.38M 21.13M 2022-03
Takeda JPY 4.27T 81.29B 2025-12
Teva Pharmaceutical Industries USD 14.99B 1.78B 2025-12
Zoetis USD 9.04B 1.97B 2025-12